Article Text
Statistics from Altmetric.com
QUESTION: In patients with social phobia, is paroxetine effective for reducing symptoms?
Design
Randomised {allocation concealed*}†, blinded {clinicians, patients, outcome assessors, and statisticians}*†, placebo controlled trial with 12 week follow up.
Setting
39 centres in Belgium, France, Germany, Ireland, South Africa, Spain, and the United Kingdom.
Patients
290 patients who were ≥18 years of age (mean age 36 y, 54% women) and had a primary diagnosis of social phobia according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, criteria. Exclusion criteria included any other recent Axis 1 disorder, serious medical disorders, or recent use of psychotropic drugs or psychotherapy. 73% of patients completed the study, and 97% were analysed.
Intervention
Patients were allocated to paroxetine, 20 mg/day initially and increased …
Footnotes
-
Source of funding: SmithKline Beecham Pharmaceuticals.
-
For correspondence: Dr D Baldwin, Mental Health Group, University of Southampton, Royal South Hants Hospital, Brintons Terrace, Southampton SO14 0YG, UK. Fax +44 (0)1703 234243.
↵† Information supplied by author.
↵‡ Difference in mean change and CI calculated from data in article.